The IMID Forum

Jan 22 2025 338 ep. 18 mins 55
The IMID Forum Podcast artwork

Keeping you up to date with the latest and most important updates in immune-mediated inflammatory diseases.

  Education
RSS feed Share
Copy RSS


Subscribe on Podcast Addict


Discussing RA: Insights into sustained DMARD-free remission and barriers to CAR T-cell therapy

Jan 22 2025 11 mins  
Join Professor Iain McInnes for the latest episode on The Immune-Mediated Inflammatory Disease Forum, where he discusses the latest updates in RA. In this episode, Professor McInnes discusses two papers: subgroups of patients with early RA with or without bDMARD who reached sustained DMARD-free remission and barriers to the widespread adoption of CAR T-cell therapy in rheumatic d

Discussing RA: Insights into Filgotinib and Tofacitinib in RA

Dec 18 2024 24 mins  
Join Professor Iain McInnes and Professor Rieke Alten for the latest episode on The Immune-Mediated Inflammatory Disease Forum, where they discuss the latest updates in RA. In this episode, they discuss two papers which discuss the efficacy and safety of filgotinib, and lymphocyte count and infection risk associated with tofacitinib in rheumatoid arthritis.

Discussing AxSpA Podcast: Efficacy and Safety of Upadacitinib

Dec 18 2024 18 mins  
Join us for the latest axSpA podcast brought to you by the Immune-Mediated Inflammatory Disease Forum! This month, Dr Sofia Ramiro is joined by Professors Hideto Kameda, Atul Deodhar, and Xenfon Baraliakos to discuss a recent study on the efficacy and safety of upadacitinib in patient with ankylosing spondylitis.

PsA Podcast: DISCOVER-2 and BE OPTIMAL/BE COMPLETE post-hoc analyses

Nov 27 2024 30 mins  
Join Professors Peter Nash and Philip Mease as they discuss the top publications in the world of PsA. This month, the conversation covered a post hoc analysis examining the rapid and sustained efficacy of bimekizumab in PsA patients across different subgroups, focusing on improvements in pain, fatigue, and physical function over 16 weeks. The conversation also covered a long-term a

ACR 2024 Review Podcast

Nov 27 2024 50 mins  
ACR 2024 Review Podcast by The Immune-Mediated Inflammatory Disease Forum

Discussing RA: Insights into Filgotinib and Tofacitinib in RA

Nov 13 2024 19 mins  
Join Professor Iain McInnes and Professor Johannes Bijlsma for the latest episode on The Immune-Mediated Inflammatory Disease Forum, where they discuss the latest information and data in RA. In this episode, they discuss two papers which discuss the efficacy and safety of filgotinib, and lymphocyte count and infection risk associated with tofacitinib in rheumatoid arthritis.

Webinar Highlights Podcast: CAR T-cell Therapy: An Emerging Therapy in Autoimmune Diseases

Nov 12 2024 26 mins  
Webinar Highlights Podcast: Join Professor Iain McInnes and Professor Georg Schett as they discuss the recent webinar hosted on the IMID Forum: “CAR T-cell Therapy: An Emerging Therapy in Autoimmune Diseases”. Listen to them discuss key highlights from the webinar including the development of CAR T-cell therapy, the application of CAR T to autoimmune diseases, and the potential

ACR 2024: Preview Podcast

Nov 10 2024 19 mins  
ACR 2024: Preview Podcast by The Immune-Mediated Inflammatory Disease Forum

ACR 2024 Highlights: Day 3

Nov 10 2024 4 mins  
ACR 2024 Highlights: Day 3 by The Immune-Mediated Inflammatory Disease Forum

ACR 2024 Highlights: Day 2

Nov 10 2024 3 mins  
ACR 2024 Highlights: Day 2 by The Immune-Mediated Inflammatory Disease Forum